Title: Thyroid Dysfunction in End Stage Renal Disease

Authors: Dr B. Nandini Priyanka, Dr S. Balasubramaniyan, Dr N. Paari

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i10.143

Abstract

The study is aimed to look at the prevalence of thyroid disorder in end stage renal disease. The data was collected from the patients reported to dialysis unit, OPD and wards. During the duration of 1 year, 30 patients who had been treated for chronic kidney disease had been followed up. Patients with chronic kidney disease confirmed by imaging and creatinine clearance, patients on hemodialysis were included in this study. Patients on thyroid hormone replacements, anti thyroid drugs, steroid and hormone therapy were excluded.In our observation, 9 patients (30%) had been diagnosed to have hypothyroidism. Among them, clinical features and investigations found out 2 patients with clinical hypothyroidism and 7 patients with subclinical hypothyroidism. No incidence of hyperthyroidism have been observed. In summary, this study finds that hypothyroidism is not unusual in all stages of chronic kidney disorder patients and reveals the significant association between chronic kidney sickness and thyroid disorder.

Keywords: Chronic kidney disease, Thyroid Dysfunction, End Stage Renal Disease, Hypothyroidism, Subclinical Hypothyroidism.

References

  1. API Texbook of Medicine, 10th Edition, Editor in Chief- YP MUNJAL
  2. Indian Journal of Nephrology May 2015 / Vol 25 / Issue 3 133
  3. Lo JC, Chertow GM, Go AS, Hsu CY. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int. 2005;67:1047–52. 
  4. Wiederkehr MR, Kalogiros J, Krapf R. Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients.  Nephrol Dial Transplant.  2004; 19:1190–7. 
  5. Indian J Endocrinol Metab. 2012 Mar-Apr; 16(2): 204–213.doi:   4103/22308210.93737PMCID: PMC3313737 Interactions between thyroid disorders and kidneydisease.
  6. Serum reverse triiodothyronine and thyroxine kinetics in patients with chronic renal failure.Kaptein EM, Feinstein EI, Nicoloff JT, Massry SGJ Clin Endocrinol Metab. 1983 Jul; 57(1):181-9.
  7. Singh PA, Bobby Z, Selvaraj N, Vinayagamoorthi R. An evaluation of thyroid hormone status and oxidative stress in undialyzed chronic renal failure patients. Indian J Physiol Pharmacol. 2006;50:279–84.
  8. Thyroid Hormone Replacement Therapy Attenuates the Decline of Renal Function in Chronic Kidney Disease Patients with Subclinical Hypothyroidism Dong Ho Shin,1 Mi Jung Lee,2 Hye Sun Lee,3 Hyung Jung Oh,2 Kwang Il Ko,2 Chan Ho Kim,2 Fa Mee Doh,2 Hyang Mo Koo,2 Hyoung Rae Kim,2 Jae Hyun Han,2 Jung Tak Park,2 Seung Hyeok Han,2 Tae-Hyun Yoo,2 and Shin-Wook Kang 2,4
  9. Lim VS. Thyroid function in patients with chronic renal failure. Am J Kidney Dis 2001; 38: 80-84.
  10. Shari Leventhal, prevalence of subclinical hypothyroidism in patients in CKD, sep.2008 issue of Clinical Journal of the American Society of Nephrology (CJASN).

Corresponding Author

Dr B. Nandini Priyanka

Post Graduate, Department of Medicine,

RMMCH, Chidambaram-608002,Tamilnadu